About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/21/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/21/2021.

Comparison of Weight-based Versus External Ear-size Based Technique for Selection of Laryngeal Mask Airway in Pediatric Surgical Patients.

Clinicaltrials.gov identifier NCT03931122

Recruitment Status Recruiting

First Posted April 30, 2019

Last update posted January 2, 2020

Study Description

Brief summary:

Laryngeal Mask Airway (LMA) is widely used in pediatric surgical patients. The manufacturer recommends the size of LMA to be used in children should be based on actual body weight but this method has several limitations. To overcome these concerns, various alternatives have been tried by different researchers, one of them is external ear size for LMA size selection. Investigators therefore would like to know whether the external ear size based method can be used for LMA size selection in pediatric surgical patients in Pakistan.

  • Condition or Disease:Pediatrics
    Laryngeal Masks
    Minors
    Child
  • Intervention/Treatment: Device: Ear Size Based Method (Ambu® AuraOnce™ Laryngeal Mask Airway)
  • Phase: N/A
Detailed Description

OBJECTIVE: to determine whether external ear-size is non-inferior to weight for LMA size selection in pediatric surgical patients. INTRODUCTION: The Laryngeal Mask Airway (LMA) is widely used in pediatric population. The manufacturer recommends the size of LMA to be used in children should be based on actual body weight. However, this method has several limitations, the range of weight for a particular size is very wide, it may not be appropriate for overweight or underweight children as it is based on actual body weight rather than ideal body weight, in emergency situations where weight of the patient is unknown the correlation between weight and size of LMA is impossible, and finally weight based recommendation may not be suitable as development of the child's oropharyngeal cavity is related to height and age rather than weight. All these factors may lead to inappropriate size selection, which may result in larger sized LMA causing trauma/injury to the airway and smaller ones causing obstruction or insufficient ventilation. To overcome these concerns various alternatives to weight based technique have been tried by different researchers in both adult and pediatric patients, one of them is external ear size. Literature revealed differences in external ear size dimensions in different ethnic population and the investigator's literature search failed to reveal any local data/study in Pakistani pediatric patients where external ear size was compared or used for size selection of the LMA. The investigators therefore would like to know whether the external ear size based method can be used for LMA size selection in pediatric surgical patients in Pakistan. HYPOTHESIS: External ear-size based technique is not inferior to weight based technique for LMA selection in pediatric population.

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 136 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: All Laryngeal Mask Airways (LMA) devices being used in the study will be Ambu® AuraOnce™ (Ambu® A/S Baltorpbakken 13 DK-2750 Ballerup, Denmark) LMA's. LMA Size Selection: will be done for each patient according to group allocation: Group A - Weight based method Group B - Ear Size Based method Randomization technique: Patients will be randomized according to computer-generated blocked randomization (https://www.sealedenvelope.com) with blocks size of 6, by independent statistician (Anaesthesia research cell). Allocation concealment will be ensured by enclosing assignments in sealed, opaque, sequentially numbered envelopes which will be opened by one of the investigator only upon arrival of the patient in the operation room.
  • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Primary Purpose: Prevention
  • Official Title: Comparison of Weight-based Versus External Ear-size Based Technique for Selection of Laryngeal Mask Airway in Pediatric Surgical Patients.
  • Actual Study Start Date: December 2019
  • Estimated Primary Completion Date: June 2021
  • Estimated Study Completion Date: July 2021
Arms and interventions
Arm Intervention/treatment
Experimental: Group B - Ear Size Based Method
Ear Size Based method: External ear size will be measured by using a paper ruler and will be recorded in cm as follows: Vertical length: will be measured from the most dependent portion of the lobule to the furthest portion of the auricle. Horizontal length (width): from the tragus to the furthest part of the helix horizontally. Dimension(cm2): Vertical length (L) × Horizontal length (width-W ) Based on these ear measurements, nearest smaller LMA size will be selected.
Device: Ear Size Based Method (Ambu® AuraOnce™ Laryngeal Mask Airway)
The Laryngeal Mask Airway (LMA) is one of the devices used to maintain airway during general anesthesia. Its appropriate size is selected according to patients body weight as recommended by the manufacturer. However its appropriate size can also be selected via several other methods and one of them is patients external ear size. In this study the investigators will compare external ear size based method for LMA selection with the standard weight based method for LMA size selection. Vertical Ear length: will be measured from the most dependent portion of the lobule to the furthest portion of the auricle. Horizontal Ear length (width): from the tragus to the furthest part of the helix horizontally. Dimension(cm2): Vertical length (L) × Horizontal length (width-W) LMA Size LMA Cuff Length (cm) corresponding to vertical ear length. LMA Cuff Width (cm) corresponding to horizontal ear width.
Outcome Measures
  • Primary Outcome Measures: 1. Adequacy of Ventilation [ Time Frame: 1 minute ]
    Adequacy of ventilation: will be judged by an oxygen saturation of greater than or equal to 95% at a Fractional Inspired Oxygen concentration (FiO2) less than 0.5 and an end-tidal carbon dioxide (ETCO2) of 35-45 mmHg at a tidal volume of 6- 8 ml/kg Actual Body Weight (ABW) at peak airway pressure less than the oropharyngeal leak pressure (OLP), and by adjusting the respiratory rate (RR).
  • 2. Proper Placement [ Time Frame: 1 minute ]
    Proper LMA placement will be assessed by chest expansion on positive pressure ventilation, absence of audible leak and a square wave capnograph waveform.
  • Secondary Outcome Measures: 1. Oropharyngeal Leak Pressure (OLP) [ Time Frame: 30 seconds ]
    Oropharyngeal Leak Pressure (OLP): will be determined at LMA intra-cuff pressure of 60 cmH2O by closing the Adjustable Pressure Limiting (APL) valve of the circle system at a fixed gas flow of 3 Liters per minute and by noting the circuit pressure at which an equilibrium will be reached and then releasing it completely.
  • 2. Leak fraction (LF) [ Time Frame: 1 minute ]
    Leak fraction (LF): will be determined by comparing the difference between inspired and expired tidal volumes and dividing them by the inspired tidal volume at a tidal volume (TV) of 8 ml/kg actual body weight (ABW) with an I:E ratio of 1:2 and respiratory rate (RR) of 20 breaths per minute.
  • 3. Incidence of mucosal injury and laryngospasm [ Time Frame: 1 minute ]
    Incidence of mucosal injury in the two groups will be assessed by trauma or minor injury to the airway seen as blood on the device after removal. Incidence of laryngospasm will also be noted.
Eligibility Criteria
  • Ages Eligible for Study: 6 to 18 Months (Child)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: Yes
Criteria

Inclusion Criteria:

1. All children aged between 6 months to 18 years of age of either sex

2. American Society of Anesthesiologist (ASA) Classification I-II

3. Elective surgical procedures in whom an LMA will be indicated

4. Procedure lasting up to 2hrs

Exclusion Criteria:

1. Any external ear morphological abnormality

2. Previous external ear surgeries

3. Patient/Parent refusal

4. Children with oropharyngeal lesion

5. Any patient conditions (Gastroesophageal Re-flux Disease [GERD], hiatal hernia,
incomplete NPO, bowel obstruction etc.) or procedures requiring rapid sequence
induction and intubation

6. History of Upper respiratory tract infection (URTI) within the last 2 weeks

Contacts and Locations
Contacts

Contact: Dr. Muhammad Qamarul Hoda, FCAI 0092-21-3486-4631 ext 4631 qamar.hoda@aku.edu

Contact: Dr. Hameed Ullah, FCPS 0092-21-3486-2898 ext 2898 hameed.ullah@aku.edu

Locations

Pakistan, Sindh
Dr. Muhammad Qamarul Hoda
Karachi

Sponsors and Collaborators

Aga Khan University

Investigators

Principal Investigator: Dr. Muhammad Qamarul Hoda, FCAI The Aga Khan University Hospital, Karachi, Pakistan.

Principal Investigator: Dr. Ali Asghar, FCPS The Aga Khan University Hospital, Karachi, Pakistan.

Principal Investigator: Dr. Hameed Ullah, FCPS The Aga Khan University Hospital, Karachi, Pakistan.

Principal Investigator: Dr. Samie Asghar Dogar, FCPS The Aga Khan University Hospital, Karachi, Pakistan.

Principal Investigator: Dr. Muhammad Saad Yousuf, FCPS The Aga Khan University Hospital, Karachi, Pakistan.

More Information